Peter Ashley Marks bought $24k of ATHE
director at ALTERITY THERAPEUTICS LTD. 47,620 shares at an average of $0.50, traded Aug 31, 2026, filed Sep 8, 2026.
Score components
- +15RoleDirector
- 0Trade size$24k at market
- +6Relative to holdingsHoldings up 33%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002127888-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | POpen-market purchase Ordinary sharesindirect: Lampam Pty Ltd | +47,620 | $0.50 | $24k | 191,340 | 36 d ago |
| Aug 31, 2026 | POpen-market purchase Listed option exp 31 Aug 2026derivativeindirect: Lampam Pty Ltd | -47,620 | $0.50 | $24k | 0 | 36 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.